MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, OLMA had -$17,213K decrease in cash & cash equivalents over the period. -$34,527K in free cash flow.

Cash Flow Overview

Change in Cash
-$17,213K
Free Cash flow
-$34,527K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-42,217 -74,173
Depreciation and amortization expense
43 260
Non-cash lease expense
300 575
Non-cash interest income on marketable securities
1,321 3,814
Stock-based compensation expense, including employee stock purchase plan expense
4,250 9,070
Prepaid expenses and other current assets
-347 1,307
Other assets and long-term deposits
3,911 1,738
Accounts payable
2,391 -3,566
Other current liabilities
5,902 1,451
Operating lease liabilities
-311 -620
Net cash used in operating activities
-34,527 -73,862
Purchase of equipment
0 0
Maturities of marketable securities
88,925 164,869
Purchases of marketable securities
71,652 175,718
Net cash provided by investing activities
17,273 -10,849
Issuance of shares under at-the-market offering, net of issuance costs of 166
0 0
Issuance costs for shares issued under 2024 private placement
6,514 -
Proceeds from borrowings under credit facility (note 11)
0 3,000
Proceeds from issuance of common stock under employee stock purchase plan
0 748
Issuance costs for shares issued under 2024 equity private placement
-6,514
Proceeds from exercise of stock options
41 470
Net cash (used in) provided by financing activities
41 -2,296
Net decrease in cash and cash equivalents
-17,213 -87,007
Cash and cash equivalents at beginning of period
139,480 -
Cash and cash equivalents at end of period
35,260 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals, Inc. (OLMA)